Abiraterone Acetate Treatment in Metastatic Prostate Cancer
No contributors found.
Release Date: 2024-06-19
Prostate cancer is the frequently presented malignancy in men, and it is expected that nearly 300,000 people will be diagnosed with it in the United States in 2024. Generally, the five-year survival rate is quite positive at 97.5%, but this rate drops to around 30% in cases with advenced disease. Tumors arise from changes in [...]